18 results on '"Sager, Philip T."'
Search Results
2. Abstract 11027: SGK1 Inhibition and Attenuation of the Action Potential Duration in Re-Engineered Heart Cell Models of Drug-Induced QT Prolongation
3. Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects
4. Novel oral anticoagulants and reversal agents: Considerations for clinical development
5. Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium
6. Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: A report from the Cardiac Safety Research Consortium
7. Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
8. The Thorough QT Study: Is Its Demise on the Horizon?
9. Response to Letter to the Editor by Blankfield regarding “Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium.”
10. The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development
11. Computerized Extraction of Electrocardiograms From Continuous 12-Lead Holter Recordings Reduces Measurement Variability in a Thorough QT Study
12. Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
13. Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients
14. Electrocardiographic assessment for therapeutic proteins—scientific discussion
15. Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline
16. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia: Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial
17. Investigational Class III Antiarrhythmic Agents
18. Investigational Antiarrhythmic Agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.